Answer
Taking Symtuza with apixaban is not recommended because, based on theoretical considerations, CYP3A and/or P-glycoprotein inhibition may increase apixaban concentrations and thereby increase bleeding risk.
Sources for this answer
- Symtuza 800 mg/150 mg/200 mg/10 mg film coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.5 Interaction with other medicinal products · Version 17Document updated
Sources checked